vs

Side-by-side financial comparison of Smart Sand, Inc. (SND) and Vericel Corp (VCEL). Click either name above to swap in a different company.

Vericel Corp is the larger business by last-quarter revenue ($92.9M vs $86.0M, roughly 1.1× Smart Sand, Inc.). Vericel Corp runs the higher net margin — 25.0% vs 1.4%, a 23.6% gap on every dollar of revenue. On growth, Vericel Corp posted the faster year-over-year revenue change (23.3% vs -5.8%). Smart Sand, Inc. produced more free cash flow last quarter ($20.4M vs $12.8M). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs 1.8%).

Sand 9 is a fabless Micro-electromechanical system (MEMS) company based in Cambridge, Massachusetts. Sand 9 developed a piezoelectric MEMS resonator to serve as an alternative for quartz timing devices in applications such as smart phones, low-power wireless devices, and communications infrastructure equipment.

Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.

SND vs VCEL — Head-to-Head

Bigger by revenue
VCEL
VCEL
1.1× larger
VCEL
$92.9M
$86.0M
SND
Growing faster (revenue YoY)
VCEL
VCEL
+29.1% gap
VCEL
23.3%
-5.8%
SND
Higher net margin
VCEL
VCEL
23.6% more per $
VCEL
25.0%
1.4%
SND
More free cash flow
SND
SND
$7.5M more FCF
SND
$20.4M
$12.8M
VCEL
Faster 2-yr revenue CAGR
VCEL
VCEL
Annualised
VCEL
34.6%
1.8%
SND

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SND
SND
VCEL
VCEL
Revenue
$86.0M
$92.9M
Net Profit
$1.2M
$23.2M
Gross Margin
13.0%
78.7%
Operating Margin
-3.1%
24.1%
Net Margin
1.4%
25.0%
Revenue YoY
-5.8%
23.3%
Net Profit YoY
-68.5%
17.3%
EPS (diluted)
$0.03
$0.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SND
SND
VCEL
VCEL
Q4 25
$86.0M
$92.9M
Q3 25
$92.8M
$67.5M
Q2 25
$85.8M
$63.2M
Q1 25
$65.6M
$52.6M
Q4 24
$91.4M
$75.4M
Q3 24
$63.2M
$57.9M
Q2 24
$73.8M
$52.7M
Q1 24
$83.1M
$51.3M
Net Profit
SND
SND
VCEL
VCEL
Q4 25
$1.2M
$23.2M
Q3 25
$3.0M
$5.1M
Q2 25
$21.4M
$-553.0K
Q1 25
$-24.2M
$-11.2M
Q4 24
$3.7M
$19.8M
Q3 24
$-98.0K
$-901.0K
Q2 24
$-430.0K
$-4.7M
Q1 24
$-216.0K
$-3.9M
Gross Margin
SND
SND
VCEL
VCEL
Q4 25
13.0%
78.7%
Q3 25
16.1%
73.5%
Q2 25
10.4%
73.7%
Q1 25
4.2%
69.0%
Q4 24
14.7%
77.6%
Q3 24
10.3%
71.9%
Q2 24
17.7%
69.5%
Q1 24
14.2%
68.9%
Operating Margin
SND
SND
VCEL
VCEL
Q4 25
-3.1%
24.1%
Q3 25
5.8%
5.1%
Q2 25
-0.1%
-3.2%
Q1 25
-10.8%
-24.3%
Q4 24
3.9%
24.5%
Q3 24
-7.8%
-4.3%
Q2 24
4.8%
-11.5%
Q1 24
0.9%
-10.7%
Net Margin
SND
SND
VCEL
VCEL
Q4 25
1.4%
25.0%
Q3 25
3.2%
7.5%
Q2 25
24.9%
-0.9%
Q1 25
-37.0%
-21.4%
Q4 24
4.1%
26.3%
Q3 24
-0.2%
-1.6%
Q2 24
-0.6%
-8.9%
Q1 24
-0.3%
-7.5%
EPS (diluted)
SND
SND
VCEL
VCEL
Q4 25
$0.03
$0.46
Q3 25
$0.08
$0.10
Q2 25
$0.54
$-0.01
Q1 25
$-0.62
$-0.23
Q4 24
$0.10
$0.40
Q3 24
$0.00
$-0.02
Q2 24
$-0.01
$-0.10
Q1 24
$-0.01
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SND
SND
VCEL
VCEL
Cash + ST InvestmentsLiquidity on hand
$22.6M
$137.5M
Total DebtLower is stronger
$15.0M
Stockholders' EquityBook value
$239.7M
$354.6M
Total Assets
$340.0M
$488.0M
Debt / EquityLower = less leverage
0.06×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SND
SND
VCEL
VCEL
Q4 25
$22.6M
$137.5M
Q3 25
$5.1M
$135.4M
Q2 25
$4.3M
$116.9M
Q1 25
$5.1M
$112.9M
Q4 24
$1.6M
$116.2M
Q3 24
$7.2M
$101.7M
Q2 24
$6.3M
$102.5M
Q1 24
$4.6M
$110.6M
Total Debt
SND
SND
VCEL
VCEL
Q4 25
$15.0M
Q3 25
$14.3M
Q2 25
$23.5M
Q1 25
$13.7M
Q4 24
$14.7M
Q3 24
$15.7M
Q2 24
$17.1M
Q1 24
$25.5M
Stockholders' Equity
SND
SND
VCEL
VCEL
Q4 25
$239.7M
$354.6M
Q3 25
$239.9M
$321.9M
Q2 25
$240.5M
$306.8M
Q1 25
$219.9M
$295.5M
Q4 24
$243.8M
$292.0M
Q3 24
$243.6M
$257.5M
Q2 24
$242.9M
$243.0M
Q1 24
$242.5M
$233.9M
Total Assets
SND
SND
VCEL
VCEL
Q4 25
$340.0M
$488.0M
Q3 25
$343.1M
$453.3M
Q2 25
$345.8M
$435.6M
Q1 25
$326.9M
$424.6M
Q4 24
$341.5M
$432.7M
Q3 24
$335.8M
$390.4M
Q2 24
$341.8M
$376.8M
Q1 24
$349.3M
$356.7M
Debt / Equity
SND
SND
VCEL
VCEL
Q4 25
0.06×
Q3 25
0.06×
Q2 25
0.10×
Q1 25
0.06×
Q4 24
0.06×
Q3 24
0.06×
Q2 24
0.07×
Q1 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SND
SND
VCEL
VCEL
Operating Cash FlowLast quarter
$22.4M
$15.0M
Free Cash FlowOCF − Capex
$20.4M
$12.8M
FCF MarginFCF / Revenue
23.7%
13.8%
Capex IntensityCapex / Revenue
2.3%
2.4%
Cash ConversionOCF / Net Profit
18.99×
0.65×
TTM Free Cash FlowTrailing 4 quarters
$32.5M
$24.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SND
SND
VCEL
VCEL
Q4 25
$22.4M
$15.0M
Q3 25
$18.2M
$22.1M
Q2 25
$-5.1M
$8.2M
Q1 25
$8.7M
$6.6M
Q4 24
$1.0M
$22.2M
Q3 24
$5.8M
$10.2M
Q2 24
$14.9M
$18.5M
Q1 24
$-3.9M
$7.2M
Free Cash Flow
SND
SND
VCEL
VCEL
Q4 25
$20.4M
$12.8M
Q3 25
$14.8M
$19.5M
Q2 25
$-7.8M
$81.0K
Q1 25
$5.2M
$-7.6M
Q4 24
$-840.0K
$8.5M
Q3 24
$3.7M
$-9.2M
Q2 24
$13.5M
$1.8M
Q1 24
$-5.5M
$-6.8M
FCF Margin
SND
SND
VCEL
VCEL
Q4 25
23.7%
13.8%
Q3 25
15.9%
28.8%
Q2 25
-9.1%
0.1%
Q1 25
7.9%
-14.5%
Q4 24
-0.9%
11.2%
Q3 24
5.8%
-15.9%
Q2 24
18.3%
3.4%
Q1 24
-6.6%
-13.3%
Capex Intensity
SND
SND
VCEL
VCEL
Q4 25
2.3%
2.4%
Q3 25
3.6%
3.9%
Q2 25
3.1%
12.9%
Q1 25
5.4%
27.0%
Q4 24
2.1%
18.3%
Q3 24
3.4%
33.5%
Q2 24
1.8%
31.8%
Q1 24
2.0%
27.3%
Cash Conversion
SND
SND
VCEL
VCEL
Q4 25
18.99×
0.65×
Q3 25
6.05×
4.35×
Q2 25
-0.24×
Q1 25
Q4 24
0.28×
1.12×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SND
SND

Sand$85.1M99%
Smart Systems Segment$980.0K1%

VCEL
VCEL

MACI Implants And Kits$84.1M90%
Other$8.8M10%

Related Comparisons